Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol in Children and Youth With Autism Spectrum Disorder
NCT02871349Phase 1Completed
- Sponsor
- University of Missouri
- Start
- Aug 2016
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Propanolol and MRI with Placebo and MRI (2 arms). Primary endpoint: General Social Outcomes Measure at 12 weeks. Started Aug 2016; status: completed.
02
Drugs
propranolol
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02871349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871349.